Positive trial results for dexamethasone in treating COVID-19 patients have been welcomed by the off-patent industry as demonstrating the potential for repurposing existing generic medicines to help in the fight against the coronavirus pandemic.
Dexamethasone Shows Potential Of Repurposed Generics Against COVID-19
Repurposing Existing Medicines Is Key Part Of Pandemic Solution, Industry Insists
Positive trial results for dexamethasone in treating COVID-19 patients demonstrate the potential of repurposing existing generic medicines to fight the coronavirus pandemic.
